Free Resources Library related to clinical trial innovation : Discover our recorded webinars, service flyers, experience, white papers and more related to clinical development.
Good Morning Meeting | Generalized Pairwise Comparisons (GPC): An innovative statistical method to design and analyze clinical trials
In collaboration with MVA, IDDI team is pleased to invite you to a Good Morning Meeting COPENHAGEN, DENMARK | APRIL…
Download/View
Assessing treatment efficacy in early-phase oncology trials
February 3, 2022
Join IDDI experts to get updated on efficacy assessment in early-phase trials and more! THURSDAY, FEBRUARY 3 – 9:00 –…
Download/View
Assessing activity in early-phase trials in oncology: current designs for expansion cohorts and phase 2
December 2, 2021
Be updated on different types of Bayesian and frequentist designs that may be used for expansion cohorts in phase 1…
Download/View
IDDI 30 YEAR ANNIVERSARY
2021 marks IDDI’s 30 year anniversary We are truly grateful to the 350+ pharmaceutical and biotech companies, as well as…
Read more
ASSESSING TREATMENT BENEFIT IN IMMUNO-ONCOLOGY
October 26, 2021
This webinar was presented by Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI at the 5th Annual Next…
Read more
Phase I trials in oncology: Pros and cons of current designs
October 21, 2021
Demystifying different types of Bayesian and frequentist designs that may be used for first-in-human or other types of phase I…
Download/View
Sample Size Re-Estimation as an Adaptive Design
Using the promising-zone approach can salvage an underpowered trial. Sample size Re-estimation (SSRE) is a relatively new concept, but, thanks…
Read more
Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints
Vaiva Deltuvaite-Thomas, Research Statistician, IDDI and Prof. Tomasz Burzykowski, VP Research IDDI have just published an article on operational characteristics…
Read more
Immunotherapy against cancer: Challenge and opportunities
With some of the recently developed drugs showing unprecedented response rates and consistent improvement in overall survival in some indications,…
Read more
Biostatistics and SARS-CoV-2: research, policymaking, and communication
September 21, 2021
Learn on the central role of Biostatistics in the COVID-19 Pandemia, and the multidisciplinary nature of pandemic response LISTEN TO…
Download/View